The First Affiliated Hospital of Harbin Medical University, Department of Hematology, Lymphoma Ward
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Shuye
NCT03494296: A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

Recruiting
N/A
150
RoW
patients received D-COP regimen chemotherapy
First Affiliated Hospital of Harbin Medical University
Lymphoma
12/20
12/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Shuye
NCT03494296: A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

Recruiting
N/A
150
RoW
patients received D-COP regimen chemotherapy
First Affiliated Hospital of Harbin Medical University
Lymphoma
12/20
12/26

Download Options